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The majority of protein sequence data published today is of metagenomic origin.
However, our ability to assign functions to these sequences is often hampered by our
general inability to cultivate the larger part of microbial species and the sheer amount
of sequence data generated in these projects. Here we present a combination of
bioinformatics, synthetic biology, and Escherichia coli genetics to discover biocatalysts
in metagenomic datasets. We created a subset of the Global Ocean Sampling dataset,
the largest metagenomic project published to date, by removing all proteins that
matched Hidden Markov Models of known protein families from PFAM and TIGRFAM
with high confidence (E-value > 10−5). This essentially left us with proteins with low
or no homology to known protein families, still encompassing ∼1.7 million different
sequences. In this subset, we then identified protein families de novo with a Markov
clustering algorithm. For each protein family, we defined a single representative based on
its phylogenetic relationship to all other members in that family. This reduced the dataset
to ∼17,000 representatives of protein families with more than 10 members. Based on
conserved regions typical for lipases and esterases, we selected a representative gene
from a family of 27 members for synthesis. This protein, when expressed in E. coli,
showed lipolytic activity toward para-nitrophenyl (pNP) esters. The Km-value of the
enzyme was 66.68 μM for pNP-butyrate and 68.08 μM for pNP-palmitate with kcat/Km
values at 3.4 × 106 and 6.6 × 105 M−1s−1, respectively. Hydrolysis of model substrates
showed enantiopreference for the R-form. Reactions yielded 43 and 61% enantiomeric
excess of products with ibuprofen methyl ester and 2-phenylpropanoic acid ethyl ester,
respectively. The enzyme retains 50% of its maximum activity at temperatures as low
as 10◦C, its activity is enhanced in artificial seawater and buffers with higher salt
concentrations with an optimum osmolarity of 3,890 mosmol/l.
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INTRODUCTION
The global market of industrial enzymes is estimated to have a value between $ 4.8 billion and
$ 5.1 billion and rising (BCC Research, 2014; The Freedonia Group, 2014). The biggest market
share falls to hydrolytic enzymes like proteases, amylases, esterases, and lipases (Gupta et al., 2004).
Lipolytic enzymes like lipases and esterases are of special interest for the industry, because of their
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various applications in organic chemistry (Jaeger and
Eggert, 2002). They are able to economically outcompete
some conventional chemical methods, based on their high
enantioselectivity, substrate speciﬁcity, and mild reaction
conditions (Divakar and Manohar, 2007).
Microbial lipolytic enzymes, esterases (EC 3.1.1.1) and lipases
(EC 3.1.1.3), are ubiquitous enzymes that hydrolyze organic
ester bonds in aqueous solutions. The former hydrolyze small
molecules with ester bonds, which are at least partly soluble in
water, whereas the latter display a maximum of activity toward
long-chained and insoluble triglycerides (Jaeger et al., 1999).
The active site of lipolytic enzymes is a catalytic triad
comprised of a nucleophilic serin residue, an acidic residue and
a histidin residue (Brady et al., 1990; Lowe, 1992). The structure
around the nucleophilic serin residue is called the catalytic elbow
with a G-x-S-x-G motif, where × stands for an arbitrary residue.
This catalytic elbow is the most conserved structure in this
protein family (Mala and Takeuchi, 2008). In some cases the ﬁrst
glycin in this motif can be substituted by alanine, as for example
in Lipase A from Bacillus subtilis (Dartois et al., 1992). The so-
called oxyanion hole, which occurs in one of three variants: HGx,
HGGGx, or Y is another highly conserved feature, by which
lipolytic enzymes can be classiﬁed (Pleiss et al., 2000; Widmann
et al., 2010).
As a result of the steady growth of the biocatalyst market there
is a desire for enzymes that can either catalyze the production
of new organic compounds through novel reaction pathways
or work more eﬃcient in established processes. To accomplish
these goals and obtain better biocatalysts known enzymes can be
modiﬁed via random or targeted mutation. Thus it was possible
to modify characteristics like enantioselectivity (Qian and Lutz,
2005), activity and thermal stability (Suen et al., 2004) as well as
substrate speciﬁcity (Reetz et al., 2005) of lipolytic enzymes.
These procedures need a basis in form of an enzyme which
already has promising attributes. Therefore the search for novel
enzymes which exhibit such attributes is a worthwhile endeavor.
One especially promising prospect for the search for new
biocatalysts are metagenomes with their vast amount of genes
from non-cultivable bacteria. It is predicted that as few as 1%
of all bacteria can be cultivated under laboratory conditions
(Amann et al., 1995), which leaves a huge amount of possibly
interesting proteins out of reach of classical genomics (Tringe
and Rubin, 2005). DNA from environmental samples is either
being sequenced and the sequencing results saved in databases
for further investigations via bioinformatics as was done with
the results from the Global Ocean Sampling (GOS; Rusch et al.,
2007; Yooseph et al., 2007), GOS, or it is transformed into an
organism for expression to construct an environmental DNA
library which can be screened for the desired activity. The latter
has been used frequently to search for novel lipolytic enzymes
(e.g., Henne et al., 2000; Lee et al., 2006; Nacke et al., 2011;
Berlemont et al., 2013; Mokoena et al., 2013). This method
has also been used to discover enzymes from often diﬃcult-to-
cultivate extremophiles (Rhee et al., 2005; Tirawongsaroj et al.,
2008; Levisson et al., 2009). Lipolytic enzymes are probably the
most frequent targets of metagenomic expression library screens
(Simon and Daniel, 2011). A wide variety of diverse habitats
has been examined and lipolytic enzymes could be found in
forest soil, marine sediment and water, landﬁll leachate, and
activated sludges, to name just a few examples. Nevertheless, in
light of the ever-growing (meta-)genomic sequence information
available, one could argue that we have only scratched the surface
of the extent of enzyme biodiversity. For a comprehensive list
of reported metagenomically derived esterases and lipases see
Martínez-Martínez et al. (2013).
A downside of the aforementioned method is the sheer
expense of resources that has to be invested into the construction
and screening of these environmental gene libraries. Typical
studies performed to ﬁnd novel enzymes can encompass up
to 3 million distinct clones (Nacke et al., 2011). Here we
present an alternative approach that has the potential to
reduce the needed manpower and resources for ﬁnding novel
enzymes using metagenomic in silico data. This approach uses
a bioinformatical arrangement of metagenomic proteins into
clusters of high homology, identiﬁcation of one representative for
each cluster and functional annotation based on known structural
characteristics of the biocatalyst in question. Using the GOS
dataset as a source, we were able to identify a novel cluster
of lipases with comparatively low homology to known lipases.
The representative of this cluster shows a broad substrate range,
high activity at moderate to low temperatures and halophilic
properties.
MATERIALS AND METHODS
Annotation of Predicted Proteins with
Known Domains
To identify predicted proteins with known domains, all GOS
sequences were analyzed for domains from PfamA, PfamB,
and TIGRFAM using the hmmsearch utility from HMMER 3.0
with an inclusion threshold E-value of 10−3 and a reporting
threshold of 10−5. Domain Hidden Markov Models (HMMs)
were obtained from ftp://ftp.ebi.ac.uk/pub/databases/Pfam/ and
ftp://ftp.jcvi.org/pub/data/TIGRFAMs/ (Pfam 27, TIGRFAM 14;
Haft et al., 2003; Finn et al., 2014).
Identification of Protein Families de novo
The remaining 1.7 million sequences lacking known domains
identiﬁable via HMMs were grouped using cd-hit hierarchical
clustering in three steps (90, 75, 60% similarity), sequences
which could not be matched with other sequences in this way
were discarded. To minimize redundancy, only sequences which
resulted from cd-hit clustering by 90% similarity were used.
Similarity distances between these sequences were determined by
all-vs.-all protein BLAST. On the basis of all similarity distances
the sequences were clustered with MCL at i = 1.4 according to
van Dongen and Abreu-Goodger (2011).
Determination of Cluster
Representatives
For each de novo family, guide trees generated by MAFFT
FFT-NS-2 Strategy were used to estimate the similarity distance
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between individual family members (Katoh et al., 2002). The
sequence with the smallest total distance to all other sequences
was chosen as the representative for a family.
Search for Lipolytic Enzymes
A regular expression pattern search for the active site of
lipases and esterases was performed on all representatives from
families lacking HMM annotation which consisted of more than
10 sequences. The regular expression sequences for the three
lipase superfamilies were derived from the annotated multiple
alignment of the Lipases Engineering Database (Pleiss et al., 2000;
Widmann et al., 2010) and are stated in Table 1.
The regular expression patterns deﬁne a necessary
requirement for lypolytic activity but on its own are not
suﬃcient. These sequences can, and do, randomly occur in
unrelated proteins. We thus applied the set of HMMs of
all families listed in the Lipase Engineering Database to the
matching sequences to select for proteins that contain the
pattern in the context of a typical hydrolase fold. The protein
gi135157357 was the only candidate that matched these patterns
with an E-value ≤ 10−5. This potential lipase from the GOS
dataset (PL-GOS) was selected and the corresponding gene
synthesized (GeneArt, Regensburg, Germany). The 3D-structure
of PL-GOS was predicted using Phyre2 (Kelley et al., 2015).
To determine, if the MCL clustering-based family of PL-GOS
is indeed phylogenetically distinct from known lipases, a
phylogenic NJ-tree tree (Kuraku et al., 2013) was created based
on a MAFFT alignment of the PL-GOS family members with
members of protein family abH 15.03 (sequences obtained from
the Lipase Engineering Database) and abH 15.02 as outgroup.
MAFFT strategy G-INS-I was used. The tree was visualized using
Dendroscope 3 in a radial phylogram. abH 15.02 is not shown
and was used to deﬁne the root.
Protein Expression and Purification
The PL-GOS gene was cloned into a pTAC-MAT-Tag-2 (Sigma–
Aldrich, St. Louis, MO, USA) based vector with an ompA
signaling sequence for periplasmic expression and a pET-
11a (Merck Millipore, Billerica, MA, USA) derivative for
overexpression and puriﬁcation via his-tag (see Table 2). The
vectors were transformed into Escherichia coli strains MG1655
(periplasmic expression) and BL21 (DE3) (overexpression),
respectively, by means of heat-shock transformation creating the
strains listed in Table 2. All E. coli strains were grown in LB-
medium (Bertani, 1951; without glucose), supplemented with
100 mg L−1 ampicillin at 37◦C. Expression of protein in strain
TABLE 1 | Regular expression patterns for the identification of
carboxylester hydrolases used in this study.
Superfamily Regular expression pattern
GX “/G[EFGHILMNRSTVWY].{10,}[AG].(S[AFHKLMQTVWY]|
C[FLWY])G.{10,}[DE].{10,}H/”
GGGX “/GG([AELNRSW]|
G[FL]).{10,}[AG].S[ACFGIMSVY]G.{10,}[DE].{10,}H/”
Y “/Y.{10,}[AG].S[ANQWY]G.{10,}[DE].{10,}H/”
TABLE 2 | Strains of Escherichia coli used in this study.
E. coli strain Genotype Source
MG1655 F− λ− ilvG− rfb-50 rph-1 ATCC strain
700926, American
Type Culture
Collection
BL21 (DE3) F− ompT− gal− dcm− lon− hsdSB
(rB− mB−)λ (DE3 (lacI lacUV5-T7
gene 1 ind1 sam7 nin5))
Stratagene, Santa
Clara, CA, USA
TMMGP MG1655 pPC (pTAC-MAT-Tag-2
with N-terminal OmpAss)
This work
TMMGPK MG1655 pTM1 (Bacillus subtilis
lipA in pPC)
This work
TMMGP1503 MG1655 pTM2 (pl-gos in pPC) This work
TMBL1503 BL21 (DE3) pTM3 (pl-gos with
N-terminal His6-Tag and TEV
cleavage site in pEt-11a)
This work
TMMGPK and TMMGP1503 was induced by addition of 1 mM
IPTG to the medium 2 h prior to cell disruption for qualitative
para-nitrophenyl ester (pNP) assays with crude cell extract and
in TMBL1503 4 h prior to cell disruption for protein puriﬁcation
at an OD600 of 0.5.
Cells for crude extract for pNP-ester assays were harvested
for 30 s at 13,000× g. The pellet was resuspended in 50 mM
tris-HCl-buﬀer, pH 7.3. Crude extract was obtained by cell
disruption using a Vial Tweeter (Hielscher, Teltow, Germany) at
80% amplitude in 0.5 s intervals for 3 × 1 min and subsequent
spinning down of the insoluble cell debris for 20 min at 13,000×
g and 4◦C.
For the puriﬁcation of PL-GOS cells were harvested by
centrifugation for 30 min at 4◦C and 7,800× g. The pellet was
resuspended in 100 ml 50 mM tris-HCl-buﬀer, pH 7.3 per 10 g
wet weight including Complete EDTA-free Protease Inhibitor
Cocktail (Roche, Mannheim, Germany) (one tablet per 80 ml
solution). Next, cells were disrupted three times using a Constant
Cell Disruption System (Constant Systems, Low March, UK) at
1.9 kbar. The lysate was again supplemented with one tablet
of Complete EDTA-free Protease Inhibitor Cocktail per 80 ml
solution and 1 mM PMSF. The cell lysate was subsequently
separated from cell debris for 1 h at 4◦C and 7,800× g by
centrifugation. Supernatant was ﬁltered using 250 ml Filtropur
V50 vacuumﬁlters (Sarstedt, Nümbrecht, Germany). Puriﬁcation
and fractionation steps were performed with an ÄKTApuriﬁer
(GE Healthcare, Uppsala, Sweden). Filtrate was loaded onto a
5 ml HisTrap HP Ni-NTA-column (GE Healthcare, Uppsala,
Sweden) equilibrated with buﬀer A (50 mM sodium phosphate,
300 mM NaCl, pH 8.0). Elution was performed using 150 ml
of a gradient from 98% buﬀer A and 2% buﬀer B (=buﬀer A
containing 500 mM imidazole) to 100% buﬀer B at a ﬂow rate
of 1.67 ml min−1. 3 ml fractions were collected and analyzed by
SDS-PAGE. Fractions with the highest protein yield were uniﬁed
and his6-tagged TEV protease was added to the target protein
at a 30-fold excess. The protein solution was dialyzed against
50 mM HEPES-buﬀer in a Spektra/Por Dialysis Membrane 12–
14 kDa (Spectrumlabs, Rancho Dominguez, USA) at 4◦C. Next
the protein solution was again loaded onto a Ni-NTA-column and
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eluted with buﬀer A to remove the his6-tagged TEV protease and
the residual his6 tag. The ﬂow-through was once again dialyzed
against 50 mM HEPES-buﬀer and concentrated using 10 kDa
ﬁlter concentrators (Santorius Stedim, Göttingen, Germany).
A purity of>95% was achieved as assessed by SDS-PAGE.
Lipolytic Activity Assays
Hydrolytic activity toward triglycerides was tested using LB agar
plates containing 100 mg L−1 ampicillin, 100 μM IPTG and
either 1% (w/v) tributyrin or 1% (w/v) triolein and 0.001% (w/v)
Rhodamin B (Sigma–Aldrich, St. Louis, MO, USA). MG1655
colonies were incubated for 2 days at 37◦C. Hydrolytic activity
was indicated by clear halos around the colonies for tributyrin
and under UV light orange ﬂuorescent halos for triolein.
Lipolytic activity was tested by using pNP-esters (pNP-
butyrate, C4; pNP-octanoate, C8; pNP-decanoate, C10; pNP-
duodecanoate, C12; pNP-myristate, C14, and pNP-palmitate,
C16) (Sigma–Aldrich, St. Louis, MO, USA) as substrates.
A reaction sample containing 65 nM puriﬁed PL-GOS or 1%
(v/v) crude extract in 50 mM tris-HCl-buﬀer, pH 7.3 was kept
at a constant temperature. The reaction was started by adding
200 μM pNP-ester from a 4 mM stock in aqueous solution
with 4% ethanol, 1% acetonitrile, and 0.4% Triton-X100 and was
observed by measuring the OD405 of the sample over the course
of 10 min. To analyze the temperature optimum pNP-butyrate
was used as a substrate and reactions were repeated at diﬀerent
temperatures ranging from 10 to 45◦C. The salt concentration
optimum was detected by replacing tris-HCl-buﬀer, pH 7.3 with
artiﬁcial seawater (28.13 g/l NaCl; 3.5 g/l MgSO4·7 H2O; 2.55 g/l
MgCl2; 1.2 g/l CaCl2; 0.77 g/l KCl; 0.11 g/l NaHCO3) (Atlas, 2010)
using pNP-butyrate as the substrate at a temperature of 20◦C.
Diﬀerent osmolarities were established by adding or withholding
NaCl. For measurement of the Michaelis Menten kinetics, the
reaction was performed in tris-HCl-buﬀer, pH 7.3 with diﬀerent
substrate concentrations of pNP-butyrate and pNP-palmitate
ranging from 5to 333 μM.
For activity assays with crude extract the TMMGPK strain
expressing lipase A from B. subtilis was used as positive control,
the TMMGP strain containing an empty vector was used as a
negative control.
Detection of Enantioselectivity
Racemic (R,S)-α-(4′-isobutylphenyl)-propionic acid methyl
ester (R,S) and (R,S)-α-phenylpropionic acid ethyl ester (R,S)
were prepared from the commercially available corresponding
racemic acid by acid-catalyzed esteriﬁcation with methanol
and ethanol, respectively. The structure of the products
was conﬁrmed by 1H-NMR. For the biocatalysis reaction,
racemic ester (11 mM) was dissolved in Tris-HCl buﬀer
(50 mM, pH 7) with DMSO (10% v/v) as cosolvent. Puriﬁed
PL-GOS (0.18 mg) was added to a total volume of 1 mL
and the reaction mixture was incubated in a thermoshaker
at 37◦C and 900 rpm. The reaction was monitored by
thin layer chromatography and was stopped after 120 h,
at approximately 50% conversion. The reaction mixture
was extracted twice with methyl tert butyl ether (MTBE,
0.4 mL). The organic solvent was dried over magnesium
sulfate and removed under dry air. Substrate and product of
the methyl ester hydrolysis were separated by TLC and the
produced acid dissolved in MTBE. The acid products of both
hydrolysis reactions were converted into the corresponding
methyl esters with TMS-diazomethane (Sigma–Aldrich)
according to the instructions of the manufacturer. The optical
purity of the reactants was determined using a chiral gas
FIGURE 1 | Esterase activity of PL_GOS. (A) Hydrolysis of pNP-butyrate by PL-GOS. Crude extract from Escherichia coli MG1655 cells expressing PL-GOS
(strain TMMGP1503) and lipase A (strain TMMGPK) from Bacillus subtilis was used. Crude extract from E. coli TMMGP (empty vector) served as negative control.
Activity of crude extracts was tested in tris-HCl-buffer, pH 7.3 and artificial seawater. PL-GOS activity increased in artificial seawater, while lipase A activity decreased.
Plate based lipolytic assays with triolein/rhodamin (B) and tributyrate as substrate (C) show no lipase activity in E. coli TMMGP1503 expressing PL-GOS from a
plasmid. E. coli TMMGPK expressing Lipase A from B. subtilis was used as a positive control and E. coli TMMGP with an empty vector was used as negative control.
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FIGURE 2 | Chain length specificity of the hydrolase activity of PL-GOS. (A) pNP esters with different acid residue chain length where tested at 20◦C in
tris-HCl-Buffer, pH 7.3. Enzyme concentration was at 65 nM, substrate concentration was 200 μM. Activity is expressed relative to activity toward pNP-butyrate.
Relative preference for shorter chain length did not change with temperature, as tested in tris-HCl-Buffer (B) or osmolarity of the buffer, as tested at 37◦C (C).
Experiments for (B) and (C) were conducted once.
TABLE 3 | Enzymatic properties of PL-GOS.
Property pNP-butyrate pNP-palmitate
(apparent) Km (μM) 66.68 68.08
Vmax (μM/min) 400 50.76
kcat (s−1 ) 228 45
kcat/Km (M−1s−1) 3.4 ∗ 106 6.6 ∗ 105
Temperature optimum 19.85◦C
Osmolarity optimum 3.89 osmol/l
chromatography column (Macherey-Nagel Hydrodex-ß-
6TBDM, 25 m × 0,25 mm) in a Shimadzu GC-2010 gas
chromatograph using hydrogen as carrier gas. Using 125◦C
column temperature, α-(4′-isobutylphenyl)-propionic acid
methyl ester eluted at 14.50 min (S) and 14.80 min (R). Using
85◦C column temperature, α-phenylpropionic acid methyl
ester eluted at 15.80 min (S) and 16.30 min (R). The E-value
of the biocatalysis of α-phenylpropionic acid ethyl ester were
calculated using conversion according to gas chromatography
and eeP. E-value and conversion of the biocatalysis of α-(4′-
isobutylphenyl)-propionic acid methyl ester were calculated
using eeS and eeP according to the equation from Chen et al.
(1982).
RESULTS
Bioinformatic Search for Lipolytic
Enzymes
The GOS project is the biggest metagenomic project to date.
It contains genomic data from planktonic microorganisms
collected in oceanic surface water around the globe (Rusch et al.,
2007). The 6,123,395 sequences of potential proteins from the
GOS project were searched for potential novel lipolytic enzymes.
In a ﬁrst step, we bioinformatically assigned protein functions
to these sequences using PfamA, PfamB, and TIGRFAM HMMs.
Proteins that matched with an E-value below 10−5 were
considered as “annotated”. These annotated sequences were
removed from the protein sequence pool. The remaining 1.7
million sequences, which we considered of “unknown” function,
were clustered at 90% similarity to avoid redundancy in the
sequences. The resulting 706,208 sequences were then clustered
using the markov-clustering algorithm MCL (van Dongen and
Abreu-Goodger, 2011). This resulted in 17,795 clusters consisting
of more than 10 sequences. We then identiﬁed one representative
protein for each of these clusters. To do so, the protein with
the minimal phylogenetic distance to all other proteins in the
cluster was chosen. We argued that this protein best represents
all other members of the cluster. We then pre-screened these
representatives with a naïve motif-search for the consensus active
site sequences of the three lipase superfamilies GX, GGGX,
and Y (Table 1). This resulted in 470 sequences matching
the search criteria for class GX, 149 sequences matching the
search criteria for class GGGX and 158 sequences matching
the search criteria for class Y. While the active site sequences
are necessary but not suﬃcient for a lipase, we also used a
HMM search for the hallmark alpha/beta hydrolase fold. This
search was performed using HMMs describing the families of
the Lipase Engineering Database (Pleiss et al., 2000). The protein
gi135157357 (PL-GOS) from the GX-superfamily was the only
sequence that matched with a signiﬁcant E-value. The known
lipase family closest to PL-GOS was abH15.03 (Saccharomyces
cerevisiae lipase 2 like). A BLASTP comparison of PL-GOS and
Saccharomyces cerevisiae lipase 2 showed an identity of 25, and
42% positive amino acid matches. The closest matches in the
NCBI non-redundant sequence database using BLASTP were
uncharacterized, hypothetical proteins of Balneola vulgaris and
Gracilimonas tropica with an identity of 49% each and 69% and
68% positive amino acid matches, respectively. This potential
lipase was then synthesized and cloned into our vector systems
for periplasmic expression and overexpression.
PL-GOS is a Lipase
To test this metagenomic protein for lipase or esterase activity, we
tested activity in crude extract of E. coliMG1655 cells expressing
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FIGURE 3 | Enzymatic parameters of PL-GOS. Km and Vmax toward pNP-butyrate (A) and pNP-palmitate (B) were derived from Lineweaver–Burk plots with a
linear fit. The x-axis displays 1/[substrate] in μM−1. For pNP-butyrate the Km was 66.68 μM and Vmax was 400 μM/min. The apparent Km of pNP-palmitate was
24.18 μM with a Vmax of 50.76 μM/min. Enzyme concentration was 65 nM, assays were performed at 20◦C.
FIGURE 4 | Enantioselectivity of PL-GOS. PL-GOS preferably hydrolyzes the R-enantiomers of Ibuprofen methyl ester (A) and phenylpropionic acid methyl ester
(B). Racemic mixtures of the respective esters were incubated with PL-GOS, then products were derivatized with TMS-diazomethane and separated on a chiral gas
chromatography column.
PL-GOS from a plasmid. PL-GOS crude extract showed activity
against pNP-butyrate similar to crude extract of MG1655 cells
expressing B. subtilis lipase A, which we used as a positive control
(Figure 1A). The activity of PL-GOS could be increased by
exchanging the tris-HCl-buﬀer, pH 7.3 in the reaction solution
for artiﬁcial seawater. This also resulted in lower activity of the
positive control and suggested to us that PL-GOS could have
halotolerant properties.
From the general potential of PL-GOS to hydrolyze organic
ester bonds in substrates with long fatty acid chains like pNP-
palmitate, we concluded that PL-GOS is a lipase, though direct
hydrolytic activity toward triglycerides could not be shown in our
assays (Figures 1B,C).
PL-GOS has a Broad Range of Substrate
Chain Length
We therefore decided to determine the biochemical
characteristics of this biocatalyst in more detail. By attaching
an N-terminal His6-tag we were able to purify PL-GOS to 95%
homogeneity. Esterases typically prefer hydrophilic substrates
and thus generally show a lower activity toward substrates
with longer carbon chains. Some esterases do not show any
activity toward pNP esters with a chain length longer than C8
(Yu et al., 2010), while others have a maximum activity toward
pNP-C8 and lower activity toward shorter and longer chained
pNP-esters (Choi et al., 2004). The chain length speciﬁcity of
PL-GOS for the hydrolysis of pNP-esters was determined by
using pNP-esters with variable acid residue lengths ranging from
butyrate (C4) to palmitate (C16). PL-GOS exhibited its highest
activity toward pNP-butyrate. It showed a decrease of activity
with increasing length of the acid residue chain. The activity
toward pNP-octanoate (C8) was 47.6%, the activity toward
pNP-palmitate (C16) 13.3% of the activity toward the preferred
pNP-butyrate (C4) substrate (Figure 2). This indicates that while
PL-GOS prefers shorter chains, it hydrolyzes a broad spectrum
of substrate chain lengths, which is typical for some lipases.
Enzyme Kinetics of PL-GOS
To further characterize the activity of PL-GOS, its Michaelis
Menten kinetics toward pNP-butyrate and pNP-palmitate were
determined (Table 3). The KM of PL-GOS toward pNP-butyrate
was 66.68 μM. From our experiments we derived a kcat value of
228 s−1 and a kcat/KM value of 3.4 ∗ 106 M−1s−1 (Figure 3A).
Compared to esterases which are specialized to hydrolize ester-
bonds with short-chain fatty acids, PL-GOS shows a very high
aﬃnity for its preferred substrate, but a comparatively low Vmax
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FIGURE 5 | Temperature and osmolarity optimum of PL-GOS using
pNP-butyrate as substrate. (A) Activity was measured at different
temperatures between 10 and 45◦C in tris-HCl-buffer, pH 7.3 and set in
relation to the highest activity. An optimum temperature of 19.85◦C was
calculated by gaussian curve fitting. (B) Activity of PL-GOS at 19.85◦C in
solutions with different osmolarities made by adjusting NaCl concentrations in
artificial seawater and set in relation to the highest activity. An optimum of
3.89 osmol/l was calculated using gaussian curve fitting. (C) Influence of alkali
metal cations on the activity of PL-GOS: Artificial seawater with three times
higher osmolarity than standard was prepared by the addition of either NaCl
or KCl. No significant difference between the cationic composition of the
buffer was found. Activity in Tris-HCl for comparison.
(Choi et al., 2004; Lee et al., 2006; Yu et al., 2010). Toward
pNP-palmitate, the apparent KM of PL-GOS was measured to be
similar with 68.08 μM at substrate concentrations above 20 μM.
At lower concentrations of pNP-palmitate PL-GOS displayed
non-Michaelis Menten kinetics and the apparent KM was lower.
This might be due to the propensity of the substrate to form
micelles (see Discussion, Figures 6 and 7). The kcat value at
substrate concentrations above 20 μM, on the other hand was
signiﬁcantly lower at 45 s−1, when compared to pNP-butyrate,
resulting in a kcat/KM value of 6.6 ∗ 105 M−1s−1 (Figure 3B). The
high activity toward long-chain fatty acids suggests that PL-GOS
is a lipase. Some other lipases show a signiﬁcantly lower aﬃnity
toward pNP-palmitate when compared to PL-GOS. The lipase of
Burkholderia cepia, for example, has a KM toward pNP-palmitate
of 12 mM (Sharma et al., 2001).
PL-GOS Shows Moderate
Enantioselectivity
The lipase-catalyzed kinetic resolution of racemic chiral esters is a
widely used route for the synthesis of optically pure compounds.
To investigate a potential application of PL-GOS, we studied
the kinetic resolution of two racemic esters. Ibuprofen is a
non-steroidal inﬂammatory drug and is one of the most-sold
over-the-counter drugs (Kourist et al., 2011). Biocatalysis oﬀers
an environmentally friendly approach for the preparation of
these compounds in optically pure form. Phenylpropionic acid
is a chiral building block for pharmaceutical synthesis and is
a model compound for the conversion of profens. PL-GOS
showed promising enantioselectivity in the kinetic resolution
of esters of these compounds. It shows preference toward
the (R)-enantiomers and enantioselectivity of E = 3–4, which
allows synthesis of the products in enantioenriched form (43%ee
for Ibuprofen methyl ester and 61%ee for the ethyl ester
of phenylpropionic acid; Figure 4). This moderate selectivity
suggests a potential of PL-GOS as enantioselective biocatalyst.
PL-GOS is a Phsychrophilic and
Halotolerant Enzyme
Due to its maritime origin we speculated that PL-GOS would
be most active at mild to cold temperatures. The activity of PL-
GOS was therefore measured at diﬀerent temperatures in the
range between 10◦C and 45◦C. From this data the temperature
optimum could be interpolated to be 19.85◦C (Figure 5A;
Table 3), while still retaining 80% of its activity at 10◦C. At higher
temperatures its activity diminished and at 45◦C it showed only a
quarter of its maximum activity.
Another characteristic, which we speculated PL-GOS could
possess due to its maritime origins, was a tolerance or aﬃnity
for high salt concentrations. In our crude extract assays we
already determined that PL-GOS has a higher activity in
artiﬁcial seawater when compared to tris-HCl-buﬀer, pH 7.3.
The osmolarity optimum was therefore determined next. To do
this, diﬀerent reaction buﬀers with varying NaCl concentrations,
derived from artiﬁcial seawater, were used in a pNP-butyrate
hydrolysis assay. This revealed an osmolarity optimum of
3.89 osmol L−1, which amounts to 3.61-fold the osmolarity
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FIGURE 6 | Phylogenetic analysis of the metagenomic sequences of the cluster of potential lipases containing PL-GOS. (A) Unrooted phylogenetic tree
of all eight complete, non-redundant sequences of the PL-GOS cluster. (B) Phylogenetic tree of lipase sequences from family abH 15.03 from the Lipase Engineering
Database and the PL-GOS cluster. The PL-GOS cluster forms a discrete subfamily in the bacterial branch of abH 15.03. Sequences from family abH 15.02 were
used as an outgroup to define the root.
FIGURE 7 | Non-Michaels Menten kinetics of PL-GOS at low substrate
concentrations of pNP-palmitate. Lineweaver–Burk plot of PL-GOS
enzyme kinetics with pNP-palmitate as substrate. At low concentrations
(≤20 μM), the apparent Km of PL-GOS was 10.64 μM, at higher
concentrations the Km was higher at 68.08 μM.
of artiﬁcial seawater (Figure 5B; Table 3). Dependency of the
increased activity on Na+-ions was tested by interchanging NaCl
with KCl. No signiﬁcant diﬀerence between reaction medium
with a high concentration of NaCl or a high concentration of KCl
could be detected (Figure 5C).
DISCUSSION
We present here a combined bioinformatics/biochemistry
approach for the discovery of new biocatalytic enzymes from
metagenomic datasets. The amount of proteins encoded
in the DNA of microbial communities is enormous. In
a typical metagenomic discovery project it is therefore
necessary to create large expression libraries with 100s
of 1000s of clones and screen this library for a speciﬁc
enzyme activity. These projects have generated many new
biocatalysts (Coughlan et al., 2015). However, this process
is resource- and time-consuming and often yields only a
low hit per clone ratio typically in the range of 10−6 to
10−4 depending on the size of the DNA fragments used
(Lämmle et al., 2007). This low ratio is not necessarily the
result of a low frequency of the occurrence of proteins with
the screened-for activity, but also based on the imperfect
positioning of the genes in the expression library. With the
advent of high-throughput “next-generation” sequencing,
a bioinformatics approach can substitute the creation and
screening of an expression library. This approach allows for a
ﬁrst “screening” in silico. Once established, the bioinformatical
screening process can be applied to further metagenomic
datasets with little to no additional cost. However, high-
throughput bioinformatics cannot yet annotate every potential
protein correctly (Godzik, 2011). Thus, one disadvantage
of a discovery strategy solely based on a bioinformatic
homology search is the dismissal of protein families with a
low homology to known biocatalysts. Here we present an
approach to ﬁnd a biocatalyst through systematic application
of diﬀerent bioinformatics search methods to a metagenomic
dataset.
We identify the novel lipase PL-GOS, representative member
of a cluster of 27 potential lipase sequences in the GOS dataset.
The genes with an unambiguously predicted start and stop codon
in this cluster encode eight complete proteins (Figure 6A),
the rest encodes partial protein sequences. A phylogenetic
analysis revealed that this cluster forms a discrete bacterial
subfamily of the abH15.03 (Saccharomyces cerevisiae lipase 2 like)
family from the Lipase Engineering Database (Figure 6B). PL-
GOS a phsychrophilic and halophilic lipase. Especially toward
substrates with long carboxylic acid chains PL-GOS showed
a favorable activity when compared to other carboxylester
hydrolases (Sharma et al., 2001; Choi et al., 2004; Lee et al.,
2006; Yu et al., 2010). Due to the propensity of pNP-palmitate
to form micelles, the determination of kinetic parameters for this
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FIGURE 8 | Predicted lid structure of PL-GOS. PL-GOS was aligned with the lipase of Staphylococcus hyicus (c2hihB in the PDP database), a lipase with a
known 3D-structure and 22% identity with PL-GOS (A). The known structure of S. hyicus lipase (B) was used for 3D modeling of PL-GOS by Phyre2 (C). The lid
structures are highlighted in blue and red, respectively. In case of PL-GOS the predicted lid structure is truncated.
substrate is challenging. Indeed, the apparent KM at very low
concentrations of pNP-palmitate wasmeasurably lower than with
high and medium concentrations (Figure 7).
A Phyre2 alignment to predict the 3D structure of
PL-GOS showed highest similarity to a Staphylococcus
hyicus lipase, which is descriped to have a lid structure
(Tiesinga et al., 2007). The predicted 3D-structure of PL-
GOS shows a truncated lid (Figure 8) which further points
to PL-GOS being a lipase. However, although the Phyre2
conﬁdence score for the structural model is high (at 100.0),
its prediction is based on weak homology (22% sequence
identity), so its validity can be questioned. Furthermore, no
activity toward triglycerides could be detected in our plate
assays.
The commercial viability of biocatalysts depends on many
factors and advances in protein engineering in recent years have
shown great success in enhancing enzyme characteristics and
specializing their uses for industrial application in biocatalysts
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as a whole (Bornscheuer et al., 2012; Li and Cirino, 2014)
and carboxylesterases in particular (Widersten, 2014). The
very mild temperature requirements and interesting osmolarity
dependencies of PL-GOS in combination with its broad
substrate range could form the basis of protein engineering
enterprises.
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